Collaboration with national and international groups

The BCG has a long track record of collaborations with national or international groups which fits perfectly with the EORTC strategic plan. The expertise of EORTC Headquarters in the field of legal and regulatory issues is highly respected, and this should be considered as a strength in the context of efficient international collaboration. The MINDACT trial is an excellent example of such a collaboration.

Other examples of intergroup trials (recently closed, ongoing or under discussion) are: SUPREMO (MRC), SOFT trial (IBCSG), ALTTO (BIG), DCIS trial (TROG).

In addition we would like to mention two additional examples:

• Male Breast Cancer (BC) International Registration and Biological Characterization Program (EORTC 10085 Intergroup study). Collaboration with BIG and SWOG is foreseen in this project.
• Discussion is underway about the EORTC contributing to the UK randomized trials of Carboplatin vs. Docetaxel in Triple Negative and/or BRCA-mutant cancers.